MicroRNAs are Related to Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Resistance in Patients with Diffuse Large B-cell Lymphoma

MicroRNAs are Related to Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Resistance in Patients with Diffuse Large B-cell Lymphoma

Aim: Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) treatment failure is a rigorous problem in patients with diffuse large B-cell lymphoma (DLBCL), which usually predicts poor survival. The study explored the association of microRNAs with R-CHOP res...

Full description

Bibliographic Details
Main Authors: Haibo Huang, Junjiao Gu, Shuna Yao, Zhihua Yao, Yan Zhao, Qingxin Xia, Jie Ma, Ling Mai, Shujun Yang, Yanyan Liu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Cancer Translational Medicine
Subjects:
Diffuse large B-cell lymphoma
extranodal site involvement
gene type of cell origin
microRNAs
resistance
Online Access:http://www.cancertm.com/article.asp?issn=2395-3977;year=2015;volume=1;issue=1;spage=6;epage=10;aulast=Huang

Internet

http://www.cancertm.com/article.asp?issn=2395-3977;year=2015;volume=1;issue=1;spage=6;epage=10;aulast=Huang

Similar Items